Spasticity and Its Contribution to Hypertonia in Cerebral Palsy

Spasticity is considered an important neural contributor to muscle hypertonia in children with cerebral palsy (CP). It is most often treated with antispasticity medication, such as Botulinum Toxin-A. However, treatment response is highly variable. Part of this variability may be due to the inability...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biomed Res Int
Main Authors: Bar-On, Lynn, Molenaers, Guy, Aertbeliën, Erwin, Van Campenhout, Anja, Feys, Hilde, Nuttin, Bart, Desloovere, Kaat
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2015
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4306250/
https://ncbi.nlm.nih.gov/pubmed/25649546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/317047
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados